← Back to Search
Approaches For Enhancing Oral Bioavailability Of Peptides And Proteins.
J. Renukuntla, A. D. Vadlapudi, Ashaben Patel, Sai H S Boddu, A. Mitra
Published 2013 · Medicine
Download PDFAnalyze on Scholarcy
Oral delivery of peptide and protein drugs faces immense challenge partially due to the gastrointestinal (GI) environment. In spite of considerable efforts by industrial and academic laboratories, no major breakthrough in the effective oral delivery of polypeptides and proteins has been accomplished. Upon oral administration, gastrointestinal epithelium acts as a physical and biochemical barrier for absorption of proteins resulting in low bioavailability (typically less than 1-2%). An ideal oral drug delivery system should be capable of (a) maintaining the integrity of protein molecules until it reaches the site of absorption, (b) releasing the drug at the target absorption site, where the delivery system appends to that site by virtue of specific interaction, and (c) retaining inside the gastrointestinal tract irrespective of its transitory constraints. Various technologies have been explored to overcome the problems associated with the oral delivery of macromolecules such as insulin, gonadotropin-releasing hormones, calcitonin, human growth factor, vaccines, enkephalins, and interferons, all of which met with limited success. This review article intends to summarize the physiological barriers to oral delivery of peptides and proteins and novel pharmaceutical approaches to circumvent these barriers and enhance oral bioavailability of these macromolecules.
This paper references
Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers.
M. Morishita (2002)
Poly(L‐lysine) as a model drug macromolecule with which to investigate secondary structure and microporous membrane transport, part 2: diffusion studies
Montakarn Chittchang (2002)
Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
S. Jana (2010)
Physiology of the Gastrointestinal Tract
L. Johnson (1994)
Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
D. Liu (1999)
Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
Byoung-Yun Kim (2005)
Oral Controlled Release Technology for Peptides: Status and Future Prospects
J. Fix (2004)
A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
A. Yamamoto (1992)
Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
P. Augustijns (1993)
The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery
G. Millotti (2011)
In vivo absorption studies of insulin from an oral delivery system.
N. Jerry (2001)
Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in Rats
T. Tenma (2004)
Biodegradable microparticles for oral immunization.
D. O'hagan (1993)
Polysaccharides: a targeting strategy for colonic drug delivery
N. Shah (2011)
Effect of cell-penetrating peptides on the nasal absorption of insulin.
E. Khafagy (2009)
Intestinal absorption of insulin in the rat.
E. Danforth (1959)
Oral delivery of salmon calcitonin.
Y. H. Lee (2000)
Novel approaches for retinal drug delivery.
D. Kurz (2002)
Skin penetration enhancers.
M. Lane (2013)
Chitosan-coated solid lipid nanoparticles for insulin delivery.
P. Fonte (2012)
Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
N. Kamei (2009)
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon
H. Tozaki (1997)
Oral colon-specific drug delivery of protein and peptide drugs.
V. Sinha (2007)
Reversible lipidization for the oral delivery of leu-enkephalin
J. Wang (2006)
Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.
N. Kamei (2009)
Passive Transepithelial Absorption of Thyrotropin-Releasing Hormone (TRH) via a Paracellular Route in Cultured Intestinal and Renal Epithelial Cell Lines
D. T. Thwaites (2004)
Oral insulin: déjà vu?
I. Rubinstein (2012)
Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats
M. Hashizume (1992)
Peroral route: an opportunity for protein and peptide drug delivery.
A. Sood (2001)
Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies.
T Borchardt R (1997)
A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery.
T. Gratieri (2010)
Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds.
M. D. Del Curto (2011)
A comparison of median hearing thresholds from U.S. Navy and U.S. Army audiometric data bases.
C. D. Ridgley (1991)
Cutting-edge technologies in colon-targeted drug delivery systems
M. Patel (2011)
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
Y. Bai (2005)
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
Intestinal mucosal transport of insulin
R. J. Schilling (1990)
Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D.
D. Loe (1994)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
Synthesis, Characterization and In Vivo Efficacy of PEGylated Insulin for Oral Delivery with Complexation Hydrogels
A. Tuesca (2008)
The potential use of receptor-mediated endocytosis for oral drug delivery.
G. Russell-Jones (2001)
Nanoparticle-based targeted drug delivery.
R. Singh (2009)
The intestinal absorption of some dipeptides
H. Newey (1959)
Reversible lipidization for the oral delivery of salmon calcitonin.
J. Wang (2003)
Optimizing oral absorption of peptides using prodrug strategies.
R. Borchardt (1999)
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
Colon targeted drug delivery systems--an overview.
P. Kumar (2008)
Structural Specificity of Mucosal-Cell Transport and Metabolism of Peptide Drugs: Implication for Oral Peptide Drug Delivery
J. P. Bai (2004)
Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
S. Watanabe (1992)
Cell-penetrating peptides: breaking through to the other side.
E. Koren (2012)
Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
R. Tréhin (2004)
Colon-specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives in rats
G. Fetih (2006)
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
Ching J Lim (2005)
Systematic Investigations of the Influence of Molecular Structure on the Transport of Peptides Across Cultured Alveolar Cell Monolayers
A. N. Dodoo (2004)
Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells.
Martin J O' Neill (2011)
Oral protein delivery: a patent review of academic and industrial approaches.
M. Werle (2009)
Prodrugs: design and clinical applications
J. Rautio (2008)
The use of cyclodextrins nanoparticles for oral delivery.
J. Kanwar (2011)
Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
M. Zorko (2005)
Role of efflux pumps and metabolising enzymes in drug delivery
Suresh Katragadda (2005)
Protein and Peptide Drug Delivery: Oral Approaches
J. Shaji (2008)
Biopharmaceutics and clinical pharmacokinetics
M. Gibaldi (1977)
Oral Delivery of Peptide Drugs
J. Hamman (2012)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
Colloidal Drug Delivery Systems
J. Kreuter (1994)
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
Oral Delivery of Biologically Active Parathyroid Hormone
A. Leone-Bay (2004)
Paracellular and transcellular pathways facilitate insulin permeability in rat gut
M. Lane (2006)
Chitosan: a potential polymer for colon-specific drug delivery system
A. Gulbake (2012)
Oral biodrug delivery using cell-penetrating peptide.
E. Khafagy (2012)
A new approach to the oral administration of insulin and other peptide drugs.
M. Saffran (1986)
The effect of enzyme inhibitor and absorption site following [D‐ala2, D‐leu5]enkephalin oral administration in rats
H. J. Lee (2002)
Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
E. Khafagy (2009)
In situ-forming hydrogels for sustained ophthalmic drug delivery.
Basavaraj K Nanjawade (2007)
Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs.
T. Mizuma (2000)
In vitro assessment of archaeosome stability for developing oral delivery systems.
G. B. Patel (2000)
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
M. Kipnes (2003)
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
The Influence of Peptide Structure on Transport Across Caco-2 Cells
R. Conradi (2004)
Therapeutic opportunities in colon-specific drug-delivery systems.
M. Patel (2007)
Absorption Enhancers: Applications and Advances
B. Aungst (2011)
A preliminary study of corneal penetration of 125l‐labelled idoxuridine liposome
S. Dharma (1986)
Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues.
S. Wróblewski (2000)
In vivo protein transduction: delivery of a biologically active protein into the mouse.
S. Schwarze (1999)
Vesicular systems in ocular drug delivery: an overview.
I. P. Kaur (2004)
Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
D. I. Jones (1997)
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.
U. B. Kompella (2001)
Use of fluorescence imaging to investigate the structure and function of intestinal M cells.
A. Buda (2005)
Mucoadhesive drug delivery systems
Rahamatullah Shaikh (2011)
Interplay of Secondary Structure and Charge on the Diffusion of a Polypeptide through Negatively Charged Aqueous Pores
Montakarn Chittchang (2006)
Cyclodextrins as Mucosal Absorption Promoters of Insulin. II. Effects of β-Cyclodextrin Derivatives on α-Chymotryptic Degradation and Enteral Absorption of Insulin in Rats
Z. Shao (2004)
Oral protein delivery: Current status and future prospect
K. Park (2011)
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
J. Cheng (2005)
The effect of additives on the oral mucosal absorption of human calcitonin in rats.
Y. Nakada (1988)
Controlled Release of Polypeptides and Other Macromolecules
R. Siegel (2004)
Preactivated thiomers: Permeation enhancing properties
X. Wang (2012)
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Y. Jin (2012)
Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestine
G. Perera (2009)
Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity
H. Lee (2004)
Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties.
K. Peh (1999)
BASF Chairman Hambrecht Stands Behind Chemicals
M. Mccoy (2005)
Amino-acids, Peptides, and Proteins
R. Sheppard (1976)
Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
Vellore J. Mohanraj (2010)
Noninvasive Routes of Proteins and Peptides Drug Delivery
An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon.
H. Zhang (2002)
Cyclodextrins in drug delivery: An updated review
R. Challa (2008)
A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
M. Hichens (1983)
Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
P. F. Builders (2008)
The Effects of Backing Materials and Multilayered Systems on the Characteristics of Bioadhesive Buccal Patches
J. H. Guo (1996)
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement.
M. Varma (2003)
Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.
S. Catnach (1994)
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
Effect of trypsin inhibitor on passage of insulin across the intestinal barrier.
M. Laskowski (1958)
The potential use of receptor-mediated endocytosis for oral drug delivery 1 PII of original article:
G. Russell-Jones (1996)
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
S. Clement (2002)
Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes.
Nartaya Thirawong (2008)
Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs
V. Stella (2007)
Drug permeation enhancement via buccal route: possibilities and limitations.
S. Şenel (2001)
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
Nazila Salamat-Miller (2005)
Thiomers for oral delivery of hydrophilic macromolecular drugs
A. Bernkop-Schnürch (2004)
Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
S. Jain (2012)
Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats
A. Yamamoto (2004)
Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
A. Fasano (1998)
From sticky stuff to sweet receptors — achievements, limits and novel approaches to bioadhesion
C. Lehr (2010)
Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?".
E. Vivès (2005)
Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
F. Sharom (1996)
Cyclodextrins in peptide and protein delivery.
Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
N. Kamei (2008)
Effects of sodium salicylate on epithelial cells of the rectal mucosa of the rat: a light and electron microscopic study.
P. Sithigorngul (1983)
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
J. Radó (1976)
Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies
H. Checkoway (2012)
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
Hong Yuan (2009)
Converting peptides into drug leads by lipidation.
L. Zhang (2012)
Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.
A. Bernkop-Schnürch (1998)
Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
A. Bernkop-Schnürch (2006)
Microbially triggered drug delivery to the colon.
V. Sinha (2003)
Structures of archaebacterial membrane lipids
G. Sprott (1992)
Preactivated thiomers as mucoadhesive polymers for drug delivery
J. Iqbal (2012)
Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
G. Sprott (2003)
Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora.
F. Rafii (1990)
Hydrogels in pharmaceutical formulations.
N. Peppas (2000)
Oral delivery of insulin using pH-responsive complexation gels.
A. Lowman (1999)
Effect of Size and Charge on the Passive Diffusion of Peptides Across Caco-2 Cell Monolayers via the Paracellular Pathway
G. Pauletti (2004)
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Lichen Yin (2009)
The absorption of insulin from various regions of the rat intestine.
M. Kidron (1982)
In vitro intestinal transport of vasopressin and its analogues.
H. Vilhardt (1986)
Oral colon delivery of insulin with the aid of functional adjuvants.
A. Maroni (2012)
Effects of Polyacrylic Polymers on the Degradation of Insulin and Peptide Drugs by Chymotrypsin and Trypsin
J. M. Bai (1996)
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
M. Tomita (2004)
Therapeutic application of peptides and proteins: parenteral forever?
Zuzana Antošová (2009)
Pharmaceutical approaches to colon targeted drug delivery systems.
M. Chourasia (2003)
A novel approach using functional peptides for efficient intestinal absorption of insulin.
M. Morishita (2007)
Carrier-Mediated Intestinal Transport of Drugs
A. Tsuji (2004)
Oral delayed-release system for colonic specific delivery☆
A. Gazzaniga (1994)
Oral drug absorption enhancement by chitosan and its derivatives.
M. Thanou (2001)
How structural features influence the biomembrane permeability of peptides.
P. S. Burton (1996)
Cyclodextrins : Useful excipients for oral peptide administration ?
B. Haeberlin (1996)
Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium
G. J. Russell-Jones (2004)
Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery.
A. D. Vadlapudi (2012)
Stabilization of thymopentin and preservation of its pharmacological properties by 2‐hydroxypropyl‐β‐cyclodextrin
N. D. Brown (1993)
In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa.
E. Lecluyse (1993)
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency.
J. Liang (2005)
Emerging trends in oral delivery of peptide and protein drugs.
R. Mahato (2003)
Azo compounds in colon-specific drug delivery
M. Roldo (2007)
Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells.
P. S. Burton (1993)
In Vivo Evaluation of an Oral Salmon Calcitonin-Delivery System Based on a Thiolated Chitosan Carrier Matrix
D. Guggi (2004)
Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat
J. Pappenheimer (2005)
Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
A. Trapani (2007)
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
Modified bile acids as carriers for peptides and drugs
W. Kramer (1997)
Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.
H. Ichikawa (2003)
Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine
Yan Chen (2012)
Developments in the area of bioadhesive drug delivery systems
C. Lehr (2002)
Protein drug stability: a formulation challenge
S. Frokjaer (2005)
Ultrastructural characteristics, secretory and phagocytotic activity of Paneth cells.
G. Répássy (1979)
Targeted enteral delivery of insulin to rats
E. Touitou (1986)
Cyclodextrins as pharmaceutical solubilizers.
M. Brewster (2007)
Biodegradable microparticles as controlled release antigen delivery systems.
D. O'hagan (1991)
Intestinal Permeability Enhancement: Structure-Activity and Structure-Toxicity Relationships for Nonylphenoxypolyoxyethylene Surfactant Permeability Enhancers
E. S. Swenson (2004)
Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
I. Vavra (1974)
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Monjed Shakweh (2004)
Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer.
M. Longer (1985)
Anatomy and physiology of the gastrointestinal tract.
K. Graaff (1986)
Characterization of the hepatic canalicular membrane transport of a model oligopeptide: ditekiren.
H. Takahashi (1997)
Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.
C. Navarro (2011)
Targeted lipid based drug conjugates: a novel strategy for drug delivery.
A. D. Vadlapudi (2012)
Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial Cells
U. Jaehde (2004)
Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery
S. Hauptstein (2012)
Current prodrug design for drug discovery.
Pei-Wen Hsieh (2009)
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.
Dongho Oh (2011)
Functional expression of human P‐glycoprotein in Schizosaccharomyces pombe
K. Ueda (1993)
ChemInform Abstract: Peroral Route: An Opportunity for Protein and Peptide Drug Delivery
A. Sood (2002)
Transport of Peptidomimetic Renin Inhibitors Across Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for Self-Enhancement of Paracellular Transport Route
E. Walter (2004)
Principles of Pharmacokinetics and Pharmacodynamics
C. Devane (2009)
Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.
H. Tozaki (2001)
Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
M. A. Hurni (1993)
Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
Fang-Yi Su (2012)
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
N. Hussain (2004)
Nanoparticles in cellular drug delivery.
A. H. Faraji (2009)
In vitro evaluation of chondroitin sulphate-chitosan microspheres as carrier for the delivery of proteins
K. Maculotti (2009)
Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers
Hidetoshi Arima (2004)
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
Oral bioavailability and first-pass effects.
K. C. Kwan (1997)
pH‐Sensitive Hydrogels as Gastrointestinal Tract Absorption Enhancers: Transport Mechanisms of Salmon Calcitonin and Other Model Molecules Using the Caco‐2 Cell Model
M. Torres-Lugo (2002)
This paper is referenced by
Computational comparison of a calcium-dependent jellyfish protein (apoaequorin) and calmodulin-cholesterol in short-term memory maintenance
G. A. Morrill (2017)
A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
Stefan G Kathman (2014)
Challenge for oral delivery of middle-molecular drugs: Use of osmolarity-sensitive liposome as a drug carrier in the GI tract
K. Minami (2020)
Lessons learned from the clinical development of oral peptides
M. Karsdal (2015)
Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres
R. H. Ansary (2017)
Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability.
T. Tong (2020)
Enhanced oral bioavailability of quercetin by a new non‐aqueous self‐double‐emulsifying drug delivery system
Q. Wang (2017)
Intact anti‐LPS IgY is found in the blood after intragastric administration in mice
Xin Zhou (2019)
New approaches towards the discovery and evaluation of bioactive peptides from natural resources
N. Kang (2020)
Machine learning‐based genetic evolution of antitumor proteins containing unnatural amino acids by integrating chemometric modeling and cytotoxicity analysis
Yongkang He (2018)
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric A. Ovacik (2018)
Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles
N. Ahmad (2016)
Characterization of concanavalin A-conjugated resistant starch acetate bioadhesive film for oral colon-targeting microcapsule delivery system
Bie Pingping (2016)
Improvement of Oral Bioavailability of Lopinavir Without Co-administration of Ritonavir Using Microspheres of Thiolated Xyloglucan
A. Madgulkar (2017)
Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
Francisca Araújo (2017)
A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition
Anika Trenner (2018)
Summary and future perspectives for oral insulin delivery
T. A. Sonia (2015)
Enhanced nutrient delivery through nanoencapsulation techniques: the current trend in food industry
Ilaiyaraja Nallamuthu (2017)
Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates.
Zehedina Khatun (2014)
Efficient Mucosal Immunization by Mucoadhesive and pH-Sensitive Polymeric Vaccine Delivery System
L. Xing (2019)
Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
F. Guo (2019)
Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
U. K. Marelli (2015)
Synthesis, photophysical properties of triazolyl-donor/acceptor chromophores decorated unnatural amino acids: Incorporation of a pair into Leu-enkephalin peptide and application of triazolylperylene amino acid in sensing BSA.
S. Bag (2016)
Advances in the Study of Marine Products with Lipid-Lowering Properties
J. Zhao (2020)
Adrenomedullin – Current perspective on a peptide hormone with significant therapeutic potential
J. Fischer (2020)
Colon Targeted Protein Nanoparticles loaded Suppositories : Effective against Intestinal Parasites
Swati Chauhan (2020)
Investigation of Intestinal Absorption Enhancers: Individual vs. Blends with the Carbamoylphosphonate JS403
Reut Bitton (2018)
Mucosal immune responses induced by oral administration recombinant Bacillus subtilis expressing the COE antigen of PEDV in newborn piglets
Jialu Wang (2019)
Intramolecular Thioether Crosslinking to Increase the Proteolytic Stability of Affibody Molecules
A. Nilsson (2017)
Challenges for pulmonary delivery of high powder doses
I. Sibum (2018)
Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects
José Lopes-de-Araújo (2015)
Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin
D. Telange (2020)See more